Suppr超能文献

使用新一代腔内移植物治疗腹主动脉瘤时患者入选标准的改进。当前使用的腔内移植物之间的比较研究及文献综述。

Improvement of patient eligibility with the use of new generation endografts for the treatment of abdominal aortic aneurysms. A comparison study among currently used endografts and literature review.

作者信息

Kontopodis Nikolaos, Papadopoulos George, Galanakis Nikolaos, Tsetis Dimitrios, Ioannou Christos V

机构信息

a Vascular Surgery Unit, Department of Cardiothoracic and Vascular Surgery , University of Crete Medical School , Heraklion , Greece.

b Interventional Radiology Unit, Radiology Department , University of Crete Medical School , Heraklion , Greece.

出版信息

Expert Rev Med Devices. 2017 Mar;14(3):245-250. doi: 10.1080/17434440.2017.1281738. Epub 2017 Jan 19.

Abstract

BACKGROUND

Newer generation devices have attempted to accommodate a wider range of aortoiliac anatomies offering endovascular aneurysm repair (EVAR) to more patients with abdominal aortic aneurysms (AAAs). We aim to examine the anatomic suitability for the ultra-low profile Ovation endograft in our AAA patients and to compare them with other contemporary devices.

METHODS

158 consecutive AAA patients treated with EVAR or open surgical repair (OSR) were tested for EVAR eligibility according to the most commonly used endografts' instructions for use.

RESULTS

106 patients underwent EVAR and 52 OSR. EVAR eligibility was higher for the Ovation system (72%) compared to the rest of the devices (Incraft: 63%, Nellix: 60%, Endurant-II: 59%, Excluder: 55%, Zenith-Flex: 36%, Aorfix: 35%, P-value<0.001). Non-suitable proximal neck anatomy followed by access vessel inadequacy were the primary reasons for ineligibility.

CONCLUSION

New generation aortic endografts with innovative proximal sealing mechanisms and ultra-low profile delivery systems are increasing patient eligibility for EVAR.

摘要

背景

新一代设备试图适应更广泛的主髂动脉解剖结构,从而为更多腹主动脉瘤(AAA)患者提供血管腔内动脉瘤修复术(EVAR)。我们旨在研究超低外形的奥维申(Ovation)腔内移植物在我们的AAA患者中的解剖学适用性,并将其与其他当代设备进行比较。

方法

根据最常用的腔内移植物的使用说明,对158例接受EVAR或开放手术修复(OSR)的连续AAA患者进行了EVAR适用性测试。

结果

106例患者接受了EVAR,52例接受了OSR。与其他设备相比,奥维申系统的EVAR适用性更高(72%)(英克拉夫特(Incraft):63%,内利克斯(Nellix):60%,恩杜兰特-II(Endurant-II):59%,艾克cluder:55%,齐尼思-弗莱克斯(Zenith-Flex):36%,主动脉固定器(Aorfix):35%,P值<0.001)。近端颈部解剖结构不合适以及随后的入路血管不足是不符合条件的主要原因。

结论

具有创新近端密封机制和超低外形输送系统的新一代主动脉腔内移植物正在增加患者接受EVAR的适用性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验